Apellis Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $2.1M | 119k | 17.31 |
| 2025-03-31 | $2.9M | 132k | 21.87 |
| 2024-12-31 | $430k | 14k | 31.91 |
| 2023-06-30 | $14M | 150k | 91.10 |
| 2023-03-31 | $10M | 152k | 65.96 |
| 2022-12-31 | $4.0M | 77k | 51.71 |
| 2022-09-30 | $363k | 5.3k | 68.31 |
| 2021-12-31 | $445k | 9.4k | 47.31 |
| 2021-09-30 | $2.6M | 78k | 32.96 |
| 2021-06-30 | $1.2M | 18k | 63.19 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management